See more : PT Petrindo Jaya Kreasi Tbk (CUAN.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Pure Extracts Technologies Corp. (PULL.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pure Extracts Technologies Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Xi’an Haitian Antenna Technologies Co., Ltd. (8227.HK) Income Statement Analysis – Financial Results
- SSE PLC (SCT.DE) Income Statement Analysis – Financial Results
- Dayton & Michigan Railroad Co. PFD 8% (DMRRP) Income Statement Analysis – Financial Results
- TTEC Holdings, Inc. (TTEC) Income Statement Analysis – Financial Results
- Fujimak Corporation (5965.T) Income Statement Analysis – Financial Results
Pure Extracts Technologies Corp. (PULL.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://pureextractscorp.com
About Pure Extracts Technologies Corp.
Pure Extracts Technologies Corp. engages in the extraction and processing of cannabis, hemp, and functional mushrooms to produce oils and various derivative products in Canada. The company offers THC and CBD based extracted oils. It also engages in the development and commercialization of functional mushroom wellness products and psychedelic medical products. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. is headquartered in Pemberton, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 1.23M | 102.11K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 1.10M | 160.55K | 20.66K | 9.89K |
| Gross Profit | 0.00 | 128.18K | -58.43K | -20.66K | -9.89K |
| Gross Profit Ratio | 0.00% | 10.43% | -57.22% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 34.98K | 0.00 | 0.00 |
| General & Administrative | 0.00 | 4.21M | 12.54M | 867.28K | 103.52K |
| Selling & Marketing | 0.00 | 102.10K | 3.75M | 46.58K | 31.74K |
| SG&A | 0.00 | 4.32M | 16.28M | 79.37K | 135.26K |
| Other Expenses | 0.00 | 753.00 | 26.46K | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 5.16M | 17.03M | 79.37K | 135.26K |
| Cost & Expenses | 0.00 | 6.26M | 17.19M | 79.37K | 145.15K |
| Interest Income | 0.00 | 2.77K | 1.21K | 747.04 | 2.66K |
| Interest Expense | 0.00 | 148.81K | 205.36K | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 750.66K | 686.60K | 17.97K | 145.15K |
| EBITDA | 0.00 | -4.34M | -19.80M | -79.37K | 31.57K |
| EBITDA Ratio | 0.00% | -347.95% | -16,039.66% | 0.00% | 0.00% |
| Operating Income | 0.00 | -4.98M | -17.07M | -79.37K | -145.15K |
| Operating Income Ratio | 0.00% | -405.36% | -16,712.06% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | -366.34K | -3.86M | 747.00 | 488.00 |
| Income Before Tax | 0.00 | -5.24M | -20.69M | -78.62K | -147.81K |
| Income Before Tax Ratio | 0.00% | -426.50% | -20,265.04% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 149.56K | 231.82K | -17.97K | -2.66K |
| Net Income | 0.00 | -5.24M | -20.69M | -78.62K | -147.81K |
| Net Income Ratio | 0.00% | -426.50% | -20,265.04% | 0.00% | 0.00% |
| EPS | 0.00 | -0.05 | -0.32 | -0.04 | -0.05 |
| EPS Diluted | 0.00 | -0.05 | -0.32 | -0.04 | -0.05 |
| Weighted Avg Shares Out | 0.00 | 102.79M | 64.11M | 2.07M | 3.00M |
| Weighted Avg Shares Out (Dil) | 0.00 | 102.79M | 64.11M | 2.07M | 3.00M |
Source: https://incomestatements.info
Category: Stock Reports